Please login to the form below
The decentralisation of clinical trials is a key catalyst for innovation in artificial intelligence
By Michael Phillips
Equipping our people leaders to drive an inclusive organisation
By Mary O’Reilly (pictured) and Nikki O’Hanlon
The evolution of medical affairs – active cooperation, collaboration and communication
By Caron Kennedy
DE&I: breaking out of the echo chamber
By Sam Bremner
Improving outcomes in oncology – patient-centricity and mental health
By Miranda Stead (pictured) and Holly Ross
-
Should we stop talking about people as patients and start thinking of them as partners? After all, it is their physical and mental health and well-beingBy David Williams
-
Harnessing the power of patient intelligence can redefine your successBy Su Smith
-
Impact That MattersBy Cath Brassington-Richards
-
Patient-centricity and how HCPs can help achieve better patient outcomes through collaborationBy Ingrid Martin
-
Decentralised clinical trials: mapping patient pathways with a focus on patient-centricityBy Emily Mitchell
-
Mapping patient pathways – with a focus on patient-centricityBy Alison Dunlop
Subscribe to our email news alerts
Featured jobs
- Senior Account Executive, Medical/ Brand Communications, London
-
Highly competitive salary
- Senior Analyst, Market Access, UK, Home based
-
Highly competitive salary
-
Senior Health Psychologist, London
-
Highly competitive salary
-
Head of Health Psychology, London
-
Highly competitive salary
- Takeda and Daiichi Sankyo collaborate to create wearable device
- Scientists discover new approach to treat brain tumours
- Sanofi and Regeneron receive FDA approval for eosinophilic oesophagitis treatment
- New Pfizer initiative, ‘An Accord for a Healthier World’, launched to improve global health equity
- AstraZeneca’s COVID-19 vaccine receives EMA approval for use as third-dose booster
- NICE recommends AstraZeneca’s Imfinzi for adults with non-small cell lung cancer
- Phase 3 trial initiated to evaluate AZ's Saphnelo in lupus nephritis
- Dermavant’s Vtama receives FDA approval for plaque psoriasis
- EORTC and Pierre Fabre launch phase 3 trial for melanoma
- Using ethnography to uncover the authentic patient experience
- 11 London: first UK healthcare agency to be awarded B Corp status
- Improving Drug Access with Data Analytics
- EMA accepts Valneva’s marketing authorisation application for COVID-19 vaccine
- FDA approves Bavarian Nordic’s smallpox and monkeypox vaccine
- AstraZeneca has clearer route to Movantik approval in US
- AZ drug for opioid constipation clears phase III
- AZ's constipation drug Moventig cleared in EU
- Dermavant’s Vtama receives FDA approval for plaque psoriasis
PMHub
Envision Pharma Group
We are a global leader in the medical affairs space. Our purpose-built software and scientific solutions make us a unique...
Latest intelligence
- How ‘Greenwashing’ accusations could delay the very changes its supporters demand
- Are shouts of companies ‘greenwashing’ to provide a façade of environmental and ethical respectability causing more harm than good? Or should we call out practices that we believe are papering...
- What does the future hold for clinical trial recruitment?
- The past couple of years have raised several aspects of healthcare in the public’s consciousness – and one of the leading ones has been the role of clinical trials in...
- When is an agency not an agency?
- The PR Week UK Top 150 Consultancies prompts anticipation and curiosity. But can a virtual collective of freelancers fairly be compared and ranked against conventional agencies?...
